First-in-Human Case Study: Multipotent Adult Progenitor Cells for Immunomodulation After Liver Transplantation

Mesenchymal stem cells and multipotent adult progenitor cells (MAPCs) have been proposed as novel therapeutics for solid organ transplant recipients with the aim of reducing exposure to pharmacological immunosuppression and its side effects. In the present study, we describe the clinical course of t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Stem Cells Transl Med
Glavni autori: Soeder, Yorick, Loss, Martin, Johnson, Christian L., Hutchinson, James A., Haarer, Jan, Ahrens, Norbert, Offner, Robert, Deans, Robert J., Van Bokkelen, Gil, Geissler, Edward K., Schlitt, Hans J., Dahlke, Marc H.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2015
Teme:
Cell-Based Drug Development, Screening, and Toxicology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511146/
https://ncbi.nlm.nih.gov/pubmed/26041737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2015-0002
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items